Tumor-targeted transferrin nanoassemblies delivering olaparib and curcumin for combating BCRP-mediated resistance in triple-negative breast cancer

TNBC tumor models, Olp-Cur@Trf NAs demonstrated extended blood circulation and active tumor accumulation, resulting in markedly superior tumor growth inhibition compared to the free drug combination. Importantly, these nanoassemblies were well-tolerated with minimal systemic toxicity, as evidenced by the absence of detectable damage to major organs. Collectively, our results validated the application of Olp-Cur@Trf NAs as a promising and practical therapeutic strategy to reverse BCRP-mediated chemoresistance in TNBC, with significant implications for clinical translation.

Authors

Institutions

Publication Details

Journal
Biomaterials Science
Published
2026-11-16
DOI
https://doi.org/10.1039/d6bm01277a
Primary Topic
Nanoparticle-Based Drug Delivery
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Tumor-targeted transferrin nanoassemblies delivering olaparib and curcumin for combating BCRP-mediated resistance in triple-negative breast cancer

Dengming Zhou, Anam Razzaq, Haroon Iqbal, Asmat Ullah et al.
3 links
Biomaterials Science
Nanoparticle-Based Drug Delivery
article

Tumor-targeted transferrin nanoassemblies delivering olaparib and curcumin for combating BCRP-mediated resistance in triple-negative breast cancer

Dengming Zhou, Anam Razzaq, Haroon Iqbal, Asmat Ullah, Naveed Ullah Khan, Wang Yue
article en

Abstract

TNBC tumor models, Olp-Cur@Trf NAs demonstrated extended blood circulation and active tumor accumulation, resulting in markedly superior tumor growth inhibition compared to the free drug combination. Importantly, these nanoassemblies were well-tolerated with minimal systemic toxicity, as evidenced by the absence of detectable damage to major organs. Collectively, our results validated the application of Olp-Cur@Trf NAs as a promising and practical therapeutic strategy to reverse BCRP-mediated chemoresistance in TNBC, with significant implications for clinical translation.

Biomaterials Science
Guangdong Medical College (CN), Chinese Academy of Sciences (CN), Wenzhou Medical University (CN), Soochow University (CN), Affiliated Eye Hospital of Wenzhou Medical College (CN), Hangzhou Institute of Medicine, Chinese Academy of Sciences (CN), Zhejiang University of Technology (CN)
National Natural Science Foundation of China, Chinese Academy of Sciences
Good health and well-being
Nanoparticle-Based Drug Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon